Literature DB >> 29879469

Partners-based HIV treatment for seroconcordant couples attending antenatal and postnatal care in rural Mozambique: A cluster randomized trial protocol.

Carolyn M Audet1, Erin Graves2, Ezequiel Barreto3, Caroline De Schacht3, Wu Gong4, Bryan E Shepherd4, Arifo Aboobacar5, Lazaro Gonzalez-Calvo6, Maria Fernanda Alvim3, Muktar H Aliyu7, Aaron M Kipp8, Heather Jordan2, K Rivet Amico9, Matthew Diemer10, Andrea Ciaranello11, Caitlin Dugdale12, Sten H Vermund13, Sara Van Rompaey3.   

Abstract

BACKGROUND: In resource-limited rural settings, scale-up of services to eliminate mother-to-child transmission of HIV has not been as effective as in better resourced urban settings. In sub-Saharan Africa, women often require male partner approval to access and remain engaged in HIV care. Our study will evaluate a promising male engagement intervention ("Homens para Saúde Mais" (HoPS+) [Men for Health Plus]) targeting the elimination of mother-to-child transmission in rural Mozambique.
DESIGN: We will use a cluster randomized clinical trial design to engage 24 health facilities (12 intervention and 12 standard of care), with 45 HIV-infected seroconcordant couples per clinic. The planned intervention will engage male partners to address social-structural and cultural factors influencing eMTCT based on new couple-centered integrated HIV services.
CONCLUSIONS: The HoPS+ study will evaluate the effectiveness of engaging male partners in antenatal care to improve outcomes among HIV-infected pregnant women, their HIV-infected male partners, and their newborn children. Our objectives are to: (1) Implement and evaluate the impact of male-engaged, couple-centered services on partners' retention in care, adherence to antiretroviral therapy, early infant diagnosis uptake, and mother-to-child transmission throughout pregnancy and breastfeeding; (2) Investigate the impact of HoPS+ intervention on hypothesized mechanisms of change; and (3) Use validated simulation models to evaluate the cost-effectiveness of the HoPS+ intervention with the use of routine clinical data from our trial. We expect the intervention to lead to strategies that can improve outcomes related to partners' retention in care, uptake of services for HIV-exposed infants, and reduced MTCT.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antenatal care; HIV/AIDS; Male partner engagement; Mozambique; Partners-based clinical services

Mesh:

Year:  2018        PMID: 29879469      PMCID: PMC6067957          DOI: 10.1016/j.cct.2018.05.020

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  64 in total

1.  Involving men in reproductive health: making the mandate a reality.

Authors:  I Ndong; C Steele; E Mahony
Journal:  Sex Health Exch       Date:  1998

2.  Successful discontinuation of the placebo arm and provision of an effective HIV prevention product after a positive interim efficacy result: the partners PrEP study experience.

Authors:  Patrick Ndase; Connie Celum; James Campbell; Elizabeth Bukusi; James Kiarie; Elly Katabira; Nelly Mugo; Elioda Tumwesigye; Jonathan Wangisi; Edwin Were; Justin Brantley; Deborah Donnell; Jared M Baeten
Journal:  J Acquir Immune Defic Syndr       Date:  2014-06-01       Impact factor: 3.731

3.  Evolution of couples' voluntary counseling and testing for HIV in Lusaka, Zambia.

Authors:  Elwyn Chomba; Susan Allen; William Kanweka; Amanda Tichacek; Garrett Cox; Erin Shutes; Isaac Zulu; Nzali Kancheya; Moses Sinkala; Rob Stephenson; Alan Haworth
Journal:  J Acquir Immune Defic Syndr       Date:  2008-01-01       Impact factor: 3.731

4.  Couples' voluntary counselling and testing and nevirapine use in antenatal clinics in two African capitals: a prospective cohort study.

Authors:  Martha Conkling; Erin L Shutes; Etienne Karita; Elwyn Chomba; Amanda Tichacek; Moses Sinkala; Bellington Vwalika; Melissa Iwanowski; Susan A Allen
Journal:  J Int AIDS Soc       Date:  2010-03-15       Impact factor: 5.396

5.  Retention in care during the first 3 years of antiretroviral therapy for women in Malawi's option B+ programme: an observational cohort study.

Authors:  Andreas D Haas; Lyson Tenthani; Malango T Msukwa; Kali Tal; Andreas Jahn; Oliver J Gadabu; Adrian Spoerri; Frank Chimbwandira; Joep J van Oosterhout; Olivia Keiser
Journal:  Lancet HIV       Date:  2016-03-09       Impact factor: 12.767

6.  HIV/AIDS stigma and refusal of HIV testing among pregnant women in rural Kenya: results from the MAMAS Study.

Authors:  Janet M Turan; Elizabeth A Bukusi; Maricianah Onono; William L Holzemer; Suellen Miller; Craig R Cohen
Journal:  AIDS Behav       Date:  2011-08

7.  Cost-effectiveness of first-line antiretroviral therapy for HIV-infected African children less than 3 years of age.

Authors:  Andrea L Ciaranello; Kathleen Doherty; Martina Penazzato; Jane C Lindsey; Linda Harrison; Kathleen Kelly; Rochelle P Walensky; Shaffiq Essajee; Elena Losina; Lulu Muhe; Kara Wools-Kaloustian; Samuel Ayaya; Milton C Weinstein; Paul Palumbo; Kenneth A Freedberg
Journal:  AIDS       Date:  2015-06-19       Impact factor: 4.177

8.  Community ART Support Groups in Mozambique: The Potential of Patients as Partners in Care.

Authors:  Kebba Jobarteh; Ray W Shiraishi; Inacio Malimane; Paula Samo Gudo; Tom Decroo; Andrew F Auld; Vania Macome; Aleny Couto
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

9.  Lessons learned during down referral of antiretroviral treatment in Tete, Mozambique.

Authors:  Tom Decroo; Isabella Panunzi; Carla das Dores; Fernando Maldonado; Marc Biot; Nathan Ford; Kathryn Chu
Journal:  J Int AIDS Soc       Date:  2009-05-06       Impact factor: 5.396

10.  Efficacy of enhanced HIV counseling for risk reduction during pregnancy and in the postpartum period: a randomized controlled trial.

Authors:  Suzanne Maman; Dhayendre Moodley; Heathe Luz McNaughton-Reyes; Allison K Groves; Ashraf Kagee; Prashini Moodley
Journal:  PLoS One       Date:  2014-05-13       Impact factor: 3.240

View more
  5 in total

1.  Dyadic Validation of Relational Processes in Seroconcordant Mozambican Couples: Social Support, Physician Trust, and Stigma.

Authors:  Michael B Frisby; Matthew A Diemer; Daniel E Sack; Carolyn M Audet
Journal:  AIDS Behav       Date:  2022-06-11

2.  Cost-effectiveness of couples' voluntary HIV counselling and testing in six African countries: a modelling study guided by an HIV prevention cascade framework.

Authors:  Kristin M Wall; Mubiana Inambao; William Kilembe; Etienne Karita; Elwyn Chomba; Bellington Vwalika; Joseph Mulenga; Rachel Parker; Tyronza Sharkey; Amanda Tichacek; Eric Hunter; Robert Yohnka; Gordon Streeb; Phaedra S Corso; Susan Allen
Journal:  J Int AIDS Soc       Date:  2020-06       Impact factor: 5.396

3.  A cluster randomized trial to reduce HIV risk from outside partnerships in Zambian HIV-Negative couples using a novel behavioral intervention, "Strengthening Our Vows": Study protocol and baseline data.

Authors:  Tyronza Sharkey; Kristin M Wall; Rachel Parker; Amanda Tichacek; Katina A Pappas-DeLuca; William Kilembe; Mubiana Inambao; Kalonde Malama; Alexandra Hoagland; Rosanna Peeling; Susan Allen
Journal:  Contemp Clin Trials Commun       Date:  2021-09-23

4.  Interpersonal reactivity index adaptation among expectant seroconcordant couples with HIV in Zambézia Province, Mozambique.

Authors:  Daniel E Sack; Michael B Frisby; Matthew A Diemer; Caroline De Schacht; Erin Graves; Aaron M Kipp; Almiro Emílio; Ariano Matino; Ezequiel Barreto; Sara Van Rompaey; Kenneth A Wallston; Carolyn M Audet
Journal:  BMC Psychol       Date:  2020-08-28

5.  Ease of marital communication and depressive symptom severity among men and women in rural Uganda: cross-sectional, whole-population study.

Authors:  Jordan Jurinsky; Jessica M Perkins; Bernard Kakuhikire; Viola N Nyakato; Charles Baguma; Justin D Rasmussen; Emily N Satinsky; Phionah Ahereza; Justus Kananura; Carolyn M Audet; David R Bangsberg; Alexander C Tsai
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2021-08-06       Impact factor: 4.328

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.